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Abstract
Background: Gain of 3q26 is frequently observed in squamous cell carcinomas of mucosal origin, including those
originating in the head and neck region. The human telomerase RNA component (hTERC) gene, which is located
on chromosome 3q26, encodes for an RNA subunit of telomerase that maintains the length of telomeres through
cellular divisions, and is activated in malignant diseases. The present study was designed to detect hTERC
amplification in laryngeal lesions and evaluate whether this might serve as a supportive biomarker in
histopathological analysis for in the diagnosis of laryngeal lesions.
Methods: Fluorescent in situ hybridization (FISH) was applied on formalin-fixed paraffin-embedded blocks of 93
laryngeal specimens, including 14 normal epithelium (NE), 15 mild dysplasia (Md), 18 moderate dysplasia (MD), 16
severe dysplasia (SD), 9 carcinoma in situ (CIS), and 21 invasive carcinoma (IC)).
Results: By histopathologic examination, hTERC amplification rates in NE, Md, MD, SD, CIS and IC cases were 0%
(0/14), 13.33% (2/15), 72.22% (13/18), 81.25% (13/16), 100% (9/9) and 100% (21/21), respectively. Amplification of
hTERC was significantly associated with histopathologic diagnosis (P < 0.0001). The percentage of hTERC
amplification in patients with MD, SD, CIS, and IC was significantly higher than those with NE or Md (P < 0.0001).
The number of cells with abnormal signals increased and the abnormal signal patterns were diversified with
increasing severity of laryngeal dysplasia (P < 0.0001).
Conclusions: The hTERC amplification is important in the development of laryngeal squamous cell carcinoma
(LSCC). FISH detection of hTERC amplification may provide an effective approach in conjunction with
histopathologic evaluation for differential diagnosis of laryngeal lesions.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2226606266791985
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Background
Laryngeal squamous cell carcinoma (LSCC) is the most
common type of head and neck squamous cell carci-
noma (HNSCC) [1,2]. Despite recent progress in the
diagnosis and therapeutic modalities for LSCC, the 5-
year survival rate has not improved in more than two
decades [3]. Early diagnosis of antecedent lesions in the
risk population may help to validate a prevention regi-
men and allow effective intervention that improves sur-
vival [1,2]. Therefore, it is necessary to identify target
molecules for diagnosis and for effective therapy at the
premalignant and/or early stages of LSCC.
It has been generally accepted that carcinogenesis
involves the progressive accumulation of genetic
abnormalities. Gain at 3q is a common feature of SCC,
with an overlapping area of gain at 3q26 having been
reported in SCC at different anatomic sites [4], includ-
ing lung [5,6], head and neck [7-9], cervix of the uterus
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[10,11], esophagus [12,13] and etc. The human telomer-
ase RNA component (hTERC) gene, localized on chro-
mosome 3q26, encodes the RNA component of human
telomerase, and acts as a template for the addition of
the repeat sequence [14]. Amplification of hTERC has
been identified in many tumor samples and immorta-
lized cell lines using techniques such as fluorescence in
situ hybridization (FISH) and Southern blot analysis,
suggesting that transcription is upregulated during
tumorigenesis [15]. However, the role of the hTERC
gene amplification in the carcinogenesis of LSCC has
yet to be defined.
In this study, we applied a dual-color fluorescence in
situ hybridization (FISH) panel in the detection of
hTERC and systematically analyzed FISH results among
different groups of laryngeal lesions based on histo-
pathologic diagnosis. The aim of the present study was
to characterize the amplification of hTERC and evaluate
its significance as an adjunctive tool.
Methods
Tissue collection
Patients involved in this study included 78 males and 15
females, with ages ranging between 35-78 years. All
patients were recruited between October 2007-July
2009, and samples were obtained after patients had pro-
vided written, informed consent. 20 formalin-fixed par-
affin-embedded blocks of normal laryngeal epithelium
were collected to establish the FISH detection threshold
of samples. In addition, formalin-fixed paraffin-
embedded blocks of 93 laryngeal carcinoma and precur-
sor lesions specimens were obtained from the Depart-
ment of Pathology of Beijing Tongren Hospital. The
cases included 14 normal epithelium (NE), 15 mild dys-
plasia (Md), 18 moderate dysplasia (MD), 16 severe dys-
plasia (SD), 9 carcinoma in situ (CIS), 21 invasive
carcinoma (IC). The patients had received no che-
motherapy or radiotherapy prior to surgery. Two pathol-
ogists reviewed all hematoxylin and eosin-stained slides
to confirm the diagnosis and ensure the presence of
representative tissue before FISH was performed. All
diagnoses in this research were established using 2005
WHO Classification.
The diagnostic criterias are as follows: Mild dysplasia:
the architectural disturbance and cytological atypia is
limited to the lower third of the epithelium; Moderate
dysplasia:the architectural disturbance and cytological
atypia are extended to the middle third of the epithe-
lium and the cells show moderately polymorphic,
nuclear mitoses are increased, but in the upper third of
the epithelium the cells are well differentiated and
arrange in lamellar form; Severe dyplasia:the architec-
tural disturbance and cytologic atypia extended more
than two thirds of the epithelium, there is no mature
morphology, and only in the top layer shows some
lamellar forms; Carcinoma in situ (CIS):The dysplasia of
the mucous epithelium involves the full thickness but
still not break through the basal lamina. There is no
characteristic appearance of gross findings, usually pre-
senting as thickening and whiteness of local mucosa.
Microscopically, the lesions show that the atypical cells
with large, hyperchromic nuclei spread to full thickness,
and the cell size is different. The pathologically mitotic
figures are visible and dyskeratosis, and the cell polarity
is disappeared. The lesion can involve the mucosal
glands but the basement membrane is intact.
Histological examination and fluorescent in situ
hybridization analysis
The tissues were fixed in 4% paraformaldehyde solution,
serially sectioned at 5 μm thickness and then stained
routinely with hematoxylin and eosin (H&E) following
standard procedures. The paraffin-embedded tissue sec-
tion was asayed by fluorescent in situ hybridization
(FISH) with the GP hTERC FISH kit accoding manufa-
ture’s instruction (GP Medical Technologies Ltd., Beij-
ing, China). Prior to hybridization of the paraffin-
embedded tissue sections, slides were treated as follows:
slides were rinsed with dimethylbenzene twice for 10
min for deparaffinization, then incubated in 100% etha-
nol for 5 min, an ethanol series (100%, 85% and 70%) in
turn for 2 min each for rehydration, deionized water for
3 min, then 90°C deionized water once for 30 min, 2×
saline sodium citrate (SSC) twice for 5 min, pepsin
digestion K solution (200 μg/ml) at 37°C for 8 min, 2 ×
SSC twice for 5 min, and an ethanol series (70%, 85%
and 100%) in turn for 2 min each. Slides were then air-
dried at room temperature.
The GP hTERC FISH kit (GP Medical Technologies
Ltd., Beijing, China) contains a hTERC DNA probe
(Spectrum Red) and a control chromosome 3 centro-
mere-specific probe (CSP3; Spectrum Green). The probe
mixture (2 μl probe, 7 μl hybridizing buffer and 1 μl
deionized water for each slide) was dropped onto the
slides, followed by denaturation at 83°C for 5 min.
Hybridization was subsequently performed in a humidi-
fied box at 42°C overnight. Slides were then washed in 2
× SSC containing 0.1% (v/v) NP-40 for 5 min, followed
by 70% (v/v) ethanol for 3 min and the air-dried slides
were restained with 40,6-diamidino-2-phenylindole
(DAPI) and mounted with cover slips.
Slides were analyzed (at × 1000 magnification) inde-
pendently by two observers under an Olympus BX50
fluorescence microscope (Olympus, Tokyo, Japan) with
a triple bandpass filter for simultaneous detection of
Spectrum Orange, Spectrum Green and DAPI. Images
were then acquired for both probes with Video Test-
FISH 2.0 software. For each specimen, 100 nuclei were
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evaluated. In a normal cell, the signal ratio of CSP3 to
hTERC is 2:2, whereas in abnormal cells the ratio will
be 2:3, 2:4, 2:5, 3:3, 4:4, and so on. Therefore, a cell with
3 or 4 hTERC signals, regardless of the signal numbers
of CSP3, will be considered as having an abnormal sig-
nal pattern. For a positive result with gain of the hTERC
gene, the percent of nuclei with a combination of all the
abnormal signal patterns should be more than the cutoff
value. The cutoff value was defined as the mean plus
three standard deviations of the percentage of nuclei
with a combination of all possible abnormal signal pat-
terns [16-18]. The cutoff value was calculated using 20
normal epithelium, confirmed by histopathology. In this
study, the cut-off value was 7.287%.
Statistical analysis
Chi-square test or Fisher’s exact test were used to evalu-
ate the results. A p value < 0.05 (two-sided) was consid-
ered to indicate statistically significant. All analyses were
performed with the use of the Statistical Package for the
Social Sciences, version 12.0 (SPSS Inc, Chicago, IL,
USA).
Results
hTERC amplification in association with histopathologic
evaluations
hTERC gene amplification was not observed in any of
the 14 normal epithelium analyzed (Figure 1). In con-
trast hTERC gene amplification was observed in 13.3%
(2/15) of mild dysplasia (Figure 2), 72.2% (13/18) of
moderate dysplasia (Figure 3), 81.3% (13/16) of severe
dysplasia (Figure 4), and in all 9 cases of carcinoma in
situ (Figure 5) and all 21 cases of invasive carcinoma
(Figure 6). The rate of hTERC gene amplification in
moderate dysplasia, severe dysplasia, carcinoma in situ
or invasive carcinoma was significantly higher than that
in normal mucosa and mild dysplasia (P < 0.001)(Table
1, Figure 7).
hTERC amplification patterns in association with different
types of lesions
The fluorescent signal pattern of CSP3 versus hTERC
is 2:2 in normal cells. For the 14 cases classified as
normal epithelium, all of the 22 abnormal cells exhib-
ited the 2:3 signal pattern; for the 15 mild dysplasia
and 18 moderate dysplasia cases, the 2:3 and 2:4 signal
pattern were the most common; for the 15 sereve dys-
plasia and 9 carcinoma in situ cases, the 2:3 and 2:4
signal pattern were the most common, followed by the
3:3 and 4:4 patterns; for the 21 Invasive carcinoma
cases, in the 988 abnormal cells observed the 4:4 signal
pattern was the most common, followed by the 3:3 and
5:5 patterns (Table 1). The numbers of hTERC ampli-
fied cases increased with the severity of laryngeal dis-
eases, as well as with the complexity of abnormal
signal (P < 0.001).
Discussion
In the present study, we investigated the relation
between the hTERC amplification and laryngeal lesions
using fluorescent in situ hybridization (FISH) in Chinese
Han population. We found that the percentage of
hTERC amplification in patients with moderate dyspla-
sia (MD), severe dysplasia (SD), carcinoma in situ (CIS),
and invasive carcinoma (IC) was significantly higher
than those with normal epithelium (NE) or mild dyspla-
sia (Md). The amplification of hTERC was significantly
associated with the histopathologic diagnosis.
Figure 1 A case of normal epithelium of the larynx. A. H&E stain. (magnification, ×200). B. Interphase FISH displaying a normal signal pattern
containing two copies (arrow) each of hTERC (red) and chromosome 3 centromere specific probe CSP3 (the internal control probe) (green), the
CSP3: hTERC signal pattern is 2:2 (green:red). (×1000).
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Emerging evidence suggest that transition from nor-
mal epithelium to dysplasia and squamous cell carci-
noma is related to the progressive accumulation of
genetic changes leading to a clonal population of trans-
formed epithelial cells [19]. Despite extensive research
into these genetic changes in laryngeal carcinogenesis,
reliable genetic markers with diagnostic and prognostic
value are still lacking.
Telomerase is a ribonucleoprotein enzyme that adds
the TTAGGG repeats to the chromosomal ends and
maintains chromosome integrity during DNA replica-
tion. Activation of telomerase can lead to cellular
immortalization, prevent from apoptosis and potentially
promote tumorigenesis [20]. The human telomerase
RNA component (hTERC) gene, localized on chromo-
some 3q26, encodes the RNA component of human
telomerase, constituting one of two major subunits, and
acts as a template for the addition of the repeat
sequence [21]. When hTERC is overexpressed, the cells
with critically short telomeres avoid undergoing apopto-
sis, potentially leading to tumorigenesis [15].
In our study, we detected the amplification of hTERC
by FISH in all cases of invasive carcinoma of larynx.
This result indicates demonstrated that amplification of
the hTERC gene is one of the most frequent amplifica-
tions described in LSCC, and it was increased with
increasing stage of dysplasia and had a high incidence in
invasive carcinoma. These results support a previous
study by Soder et al, which detected more than two
copies of hTERC per cell in 97% (29/30) of head and
neck squamous cell carcinoma (HNSCC) by FISH [22].
While studies employing comparative genomic
Figure 2 A case of mild dysplasia of the larynx. A. H&E stain. (×200). B. Interphase FISH displaying a CSP3: hTERC signal pattern of 2:2 (green:
red). (×1000).
Figure 3 A case of moderate dysplasia of the larynx. A. H&E stain. (×200). B. Interphase FISH displaying a CSP3: hTERC signal pattern is 2:3
(green:red). (×1000).
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Figure 4 A case of sereve dysplasia of the larynx . A. H&E stain. (×200). B. Interphase FISH displaying a CSP3: hTERC signal pattern is 2:3, 2:5,
3:3, and etc. (×1000).
Figure 5 A case of carcinoma in situ . A. H&E stain. (×200). B. Interphase FISH displaying a CSP3: hTERC signal pattern is 2:3, 4:4, 6:6, and etc.
(×1000).
Figure 6 A case of invasive carcinoma . A. H&E stain. (×200). B. Interphase FISH shows the CSP3: hTERC signal pattern is 3:4, 5:5, 5:7, and etc.
(×1000)
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hybridization (CGH) have reported lower frequency for
3q26 gains (between 50-82%) in HNSCC [23-26], this
difference is likely attributable to the different sensitivity
of the respective techniques. Detection of trisomy using
CGH requires this numerical aberration to be present in
at least 40% of the cells. In contrast, FISH detects
changes on a single-cell basis and is therefore not sensi-
tive to dilution. Furthermore, small, regional, low-copy
number amplification may escape detection by CGH
[27].
Interestingly, the amplification of hTERC was
observed at low frequency in normal epithelium and
mild dysplasia, compared with a significantly higher fre-
quency in cases of the moderate dysplasia, severe dys-
plasia, carcinoma in situ and invasive carcinoma. This
finding supports that the amplification of hTERC may
be a transition event in the progression to invasive
squamous cell carcinoma of larynx. It is in agreement
with previous studies, the gain of chromosome 3q was
reported as the most common site of genetic overrepre-
sentation in mucosal squamous cell carcinomas and has
suggested it is a pivotal transition event in cancer patho-
genesis [10,11,28]. The finding also supports the possibi-
lity for hTERC amplification as a clinically useful
genetic marker assisting histopathologic analysis for the
differential diagnosis of low-grade (< mild dysplasia) ver-
sus high-grade (> moderate dysplasia) of laryngeal dys-
plasia. The finding was consistent with results reported
by other investigators. Luzar et al demonstrated that the
presence and relative quantity of Human telomerase
reverse transcriptase (hTERT) mRNA increases progres-
sively with the degree of laryngeal epithelial abnormal-
ities. Statistical analysis revealed two groups of laryngeal
epithelial changes, with significant differences in the
levels of hTERT mRNA expression (P < 0.0033): (i) nor-
mal and reactive hyperplastic laryngeal epithelium
(squamous and basal-parabasal hyperplasia), and (ii) aty-
pical hyperplasia (potentially malignant lesion), CIS and
invasive laryngeal SCC [29]. They also found the telo-
merase catalytic protein immunohistochemistry parallels
well with hTERT mRNA relative quantities in laryngeal
carcinogenesis. The results indicate that telomerase
reactivation is an early event in laryngeal carcinogenesis,
already detectable at the stage of precancerous laryngeal
epithelial changes [30].
Gene mutations and chromosomal abnormalities are
commonly present in tumor cells. Chromosome aneu-
ploidy and structural anomalies lead to genomic
instability, resulting in tumorigenesis. In the present
study, the percentages of cells with hTERC amplification
increased with increasing severity of disease, and the
amplification patterns got more diverse and complex as
well. Notably, more complicated patterns of hTERC
amplification other than 2:3 were found only in the
high-grade lesions. The study demonstrated that chro-
mosome aneuploidy was a common event in laryngeal
lesions. Whether amplification patterns can be used as
diagnostic or prognostic markers warrants further
investigation.
Table 1 hTERC Amplification According to Histopathologic Evaluation
Laryngeal lesions Cases, no. hTERC+, no. (%) Abnormal cells, no. (%)* Proportion of amplification types, % of cases
2:3 2:4 2:5 3:3 4:4 5:5 6:6 Others 3:4,3:5, 4:5 etc.
Normal epithelium 14 0(0.0) 22(1.6) 100
Mild dysplasia 15 2 (13.3) 68 (4.5) 85.3 14.7
Moderate dysplasia 18 13 (72.2) 409 (22.7) 47.6 39.8 1.5 4.8 3.6 2.7
Sereve dysplasia 16 13 (81.3) 506(31.6) 38.6 34.6 2.7 9.8 7.6 2.8 0.4 3.5
Carcinoma in situ 9 9(100.0) 353(39.2) 28.1 24.6 3.8 17.8 14.5 6.4 1.6 3.2
Invasive carcinoma 21 21(100.0) 988 (47.0) 14.2 12.3 6.2 21.6 24.7 15.4 2.3 3.3
*Number of abnormal cells (% abnormal cells out of total cells examined, and 100 cells were observed in each case)
Figure 7 The increasing trend of hTERC amplification positive
rates associated with the severity of laryngeal lesions, for
histopathologic diagnosis.
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In conclusion, We have analyzed the amplification of
hTERC in different stages of laryngeal carcinogenesis.
The present study suggests that FISH analysis can be
performed on histological specimens in order to detect
the amplification of hTERC for the diagnosis of laryn-
geal lesions. The hTERC amplification assay may be an
adjunct to histopathologic screening and may be useful
in assessing the potential of individual lesions to
progress.
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